Sign In
Buy ADMA
$8.69
+0.120 (+1.40%)
At Close: Jun 23, 2026
The Schall Law Firm Urges Shareholders To Join An Inquiry Into ADMA Biologics, Inc. For Securities Law Violations
11:00am, Friday, 08'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm
10:21am, Friday, 08'th Nov 2024
LOS ANGELES , Nov. 8, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics, Inc.
ADMA INVESTOR NEWS: ADMA Biologics Investors with Losses May have been Affected by Fraud; Contact BFA Law (Nasdaq:ADMA)
06:37am, Friday, 08'th Nov 2024
NEW YORK, Nov. 08, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the f
ADMA Biologics, Inc. (ADMA) Q3 2024 Earnings Call Transcript
10:12pm, Thursday, 07'th Nov 2024
ADMA Biologics, Inc. (NASDAQ:ADMA ) Q3 2024 Earnings Conference Call November 7, 2024 4:30 PM ET Company Participants Skyler Bloom – Senior Director, Business Development & Corporate Strategy Adam G
Adma Biologics (ADMA) Q3 Earnings and Revenues Beat Estimates
08:21pm, Thursday, 07'th Nov 2024
Adma Biologics (ADMA) came out with quarterly earnings of $0.15 per share, beating the Zacks Consensus Estimate of $0.13 per share. This compares to earnings of $0.01 per share a year ago.
Did ADMA Biologics (ADMA) Commit Securities Fraud Resulting in 20% Stock Drop? Contact BFA Law about its Ongoing Investigation
03:47pm, Thursday, 07'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 7, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the
ADMA Biologics Inc Is Being Investigated For Securities Fraud And Investors With Losses Are Encouraged To Contact The Schall Law Firm
11:00am, Thursday, 07'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
03:15pm, Wednesday, 06'th Nov 2024
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Pomerantz LLP is investigating claims on behalf of investors of ADMA Biologics, Inc. ("ADMA" or the "Company") (NASDAQ:ADMA). Such investors are advised
NEW YORK, NY / ACCESSWIRE / November 6, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the
The Schall Law Firm Urges Shareholder Participation In An Inquiry Into ADMA Biologics, Inc. For Securities Law Violations
11:00am, Wednesday, 06'th Nov 2024
LOS ANGELES, CA / ACCESSWIRE / November 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ADMA Biologics
ADMA STOCK REPORT: ADMA Biologics Investors are Notified to Contact BFA Law about the Securities Fraud Investigation after Stock Drops 20%
06:49am, Wednesday, 06'th Nov 2024
NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ: ADMA) for potential violations of the f
Kirby McInerney LLP Announces Investigation of Shareholder Claims Against ADMA Biologics, Inc. (ADMA)
04:33pm, Tuesday, 05'th Nov 2024
NEW YORK--(BUSINESS WIRE)---- $ADMA #INVESTIGATION--The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASD
NEW YORK, NY / ACCESSWIRE / November 5, 2024 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into ADMA Biologics, Inc. (NASDAQ:ADMA) for potential violations of the
Should ADMA Biologics Stock Be in Your Portfolio Pre-Q3 Earnings?
03:06pm, Tuesday, 05'th Nov 2024
ADMA is having a stupendous run in 2024 so far on strong performance of Asceniv and high growth prospects.
ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm
09:59am, Tuesday, 05'th Nov 2024
LOS ANGELES--(BUSINESS WIRE)--ADMA Investors Have Opportunity to Join ADMA Biologics, Inc. Fraud Investigation with the Schall Law Firm.
